Name | NOVAMEDIKA INNOTEKH, OOO |
|---|
INN | 7718915102 |
|---|
KPP | 772301001 |
|---|
OGRN | 1127747268945 |
|---|
OKPO | 16879425 |
|---|
Address | 109316, G.moskva, pr-kt Volgogradskiy, d. D. 42, of. POM/KOM I/606 |
|---|
Phone | +7 (791) 532-20-80 |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 72.19 | Core activity | Research and experimental development on natural sciences and engineering Other | | 21.1 | Additional activity | Pharmaceutical substances |
Registration date | 20.12.2012 |
|---|
|
NOVAMEDIKA INNOTEKH, OOO (Moscow; INN 7718915102) was registered on 20 Dec 2012. The company's authorized capital as of July 1, 2012 was 83604000 rub. Principal activities of NOVAMEDIKA INNOTEKH, OOO: research and experimental development on natural sciences and engineering other (72.19), pharmaceutical substances (21.1). |
Economic indicators2022
Net loss (RAS) of NOVAMEDIKA INNOTEKH, OOO increased by 5.28% to 91.25 million RUB from 86.67 million RUB over 2021, the company informed. Revenue remained in the accounting period at the same level and made up 87.63 million RUB compared to 87.92 million RUB 87.92 million RUB; cost of goods sold grew by 11.10% to 120.62 million RUB from 108.57 million RUB; sales loss grew by 31.70% to 121.62 million RUB from 92.34 million RUB. 2021
Net loss (RAS) of NOVAMEDIKA INNOTEKH, OOO increased 1.51 times to 86.67 million RUB from 57.32 million RUB over 2020, the company informed. Revenue decreased in the accounting period by 28.09% to 87.92 million RUB from 122.26 million RUB in 2020; cost of goods sold grew by 1.23% to 108.57 million RUB from 107.25 million RUB; sales loss grew by 47.57% to 92.34 million RUB from 62.58 million RUB. 2020
Net loss (RAS) of NOVAMEDIKA INNOTEKH, OOO increased by 7.95% to 57.32 million RUB from 53.10 million RUB over 2019, the company informed. Revenue remained in the accounting period at the same level and made up 122.26 million RUB compared to 122.00 million RUB 122.00 million RUB; cost of goods sold decreased by 3.22% to 107.25 million RUB from 110.82 million RUB; sales loss grew by 3.16% to 62.58 million RUB from 60.66 million RUB. 2019
Net loss (RAS) of NOVAMEDIKA INNOTEKH, OOO increased by 32.99% to 53.10 million RUB from 39.93 million RUB over 2018, the company informed. Revenue increased in the accounting period by 9.79% to 122.00 million RUB from 111.12 million RUB over 2018; cost of goods sold grew by 12.55% to 110.82 million RUB from 98.47 million RUB; sales loss grew by 28.49% to 60.66 million RUB from 47.21 million RUB. 2018
Net loss (RAS) of NOVAMEDIKA INNOTEKH, OOO dropped over 2018 2.10 times to 39.93 million RUB from 83.71 million RUB KAgent.Entities.Balance, the company informed. Revenue increased in the accounting period 10.39 times to 111.12 million RUB from 10.69 million RUB over 2017; cost of goods sold grew 2.48 times to 98.47 million RUB from 39.77 million RUB; sales loss decreased by 46.23% to 47.21 million RUB from 87.80 million RUB. 2017
Net loss (RAS) of NOVAMEDIKA INNOTEKH, OOO increased 4.26 times to 83.71 million RUB from 19.64 million RUB over 2016, the company informed. Sales loss grew 2.99 times to 56.78 million RUB from 19.01 million RUB. 2016
Net loss (RAS) of NOVAMEDIKA INNOTEKH, OOO increased 265.46 times to 19.64 million RUB from 74.00 thousand RUB over 2015, the company informed. Sales loss grew 253.47 times to 19.01 million RUB from 75.00 thousand RUB. 2014
Net loss (RAS) of NovaMedika Innotekh, OOO dropped over 2014 by 11.27% to 63.00 thousand RUB from 71.00 thousand RUB KAgent.Entities.Balance, the company informed. Sales loss decreased by 5.71% to 66.00 thousand RUB from 70.00 thousand RUB. 2013
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|